Pharmaceutical Representative recently asked members of its Reader Advisory Panel to describe their new year's resolutions. If you're thinking about making a resolution, these examples may give you some good ideas.
Pharmaceutical Representative recently asked members of its Reader Advisory Panel to describe their new year's resolutions. If you're thinking about making a resolution, these examples may give you some good ideas.
•Â Gerry Levesque, a medical sales rep with Zeneca: "To be the best rep I can be despite the changing marketplace."
•Â A rep in New York: "To hit my sales numbers and be above goal by 50 percent."
•Â A rep in Iowa: "To stay focused on customer needs during a time of challenge and reorganization."
•Â Mary Beth Hagen, a Bayer area account specialist: "To organize my long-term goals and determine specific steps to reach them."
•Â Sam Armstrong, a medical rep in Virginia: "To expand my prescription and over-the-counter growth to new heights."
•Â Sherry Wilcoxson, medical representative with Otsuka America Pharmaceutical Inc.: "To continue to sell with enthusiasm on each and every call."
•Â A Dayton, OH, rep: "To be a Presi-dent's Club winner."
•Â Steve Smith, a Kentucky-based rep: "To successfully launch a new product."
•Â A rep in Des Moines, IA: "To make more money."
•Â Mary Myers, district manager for Purdue Frederick: "To coach my team to do the basics better than everyone else and move into the No. 1 district spot nationally."
•Â John Adamson, a senior health care consultant in Orlando, FL: "To do more target selling."
•Â A territory rep in Denver: "To improve on my professional development as a sales rep through Certified Medical Representatives Institute certification and more product knowledge."
•Â Jim Mangiola, a district manager in San Francisco: "To learn more ways to be an asset to the managed care environment."
•Â A rep in Virginia: "To maintain good mental and physical health while battling for market share increases."
•Â Clinton Broadway, a professional rep for Janssen: "To be a better resource for my customers and be responsive to their needs."
•Â A neuropharmacology rep in New York: "To be in sales management."
•Â Christina Strickland, a sales rep with Savage Labs: "To be among the top 10 reps in my company."
•Â Patty Van Allen, a sales consultant for Berlex Laboratories: "To improve my selling skills to increase territory sales."
•Â Kellee Ganzer, a professional rep in Wheeling, WV: "To increase my market share and win a trip."
•Â Brian Russell, a pharmaceutical sales rep with Schwarz Pharma: "To get back to the basics and plan every call in advance."
•Â A senior sales rep with Boehringer Ingelheim: "To be more innovative when working with doctors and hospitals."
•Â Letticia Atkins, a sales rep with Ortho-McNeil: "To begin my M.B.A."
•Â Thomas Blair, a senior executive rep with Fujisawa USA: "To excel and achieve individual goals through personal education and growth."
•Â Ray Grinsteinner, a medical marketing rep: "To increase discipline and decrease procrastination."
•Â A Zeneca medical sales rep in Wichita, KS: "To be a better equestrian."
•Â A pharmaceutical sales rep in Nashville, TN: "To be a better husband, father, grandfather and Christian."
•Â A professional sales rep on the East Coast: "To lose 40 pounds while on the road."
•Â A rep in Los Angeles: "To take a speed-reading course and get on-line with the Internet."
•Â An Orlando-based rep: "To narrow my focus and lessen my stress."
•Â A rep in Tacoma, WA: "To upgrade the house."
•Â Tobi Jackson, a senior hospital/institutional sales manager for Bristol-Myers Squibb: "To have better time management."
•Â Sandy Garcia, a Bayer hospital accounts specialist: "To take each day and make the most of it." PR
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.